한국어
Quantus

Zero to Seven

159580 · KOSDAQ
₩2,195+0.92%
2026-09-04 close

Zero to Seven last closed at ₩2,195 (+0.92%) on 2026-09-04. Signals today: Death cross. Listed on KOSDAQ; price, financials and dividends update daily after market close.

Loading chart…
Close
데드크로스 · 0d 전

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
303 picks
Next-day win rate
50.7%
Avg next-day
-0.11%
vs market
-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

C
Overall: 화장품,의류,완구 112/152 · top 74%
Factor composite · relative position in sector

PER 53.95 · PBR 0.33 — own-history percentile 63/100 · 100/100

Open self-history band
PER63/100
PBR100/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Annual dividend

Split-adjusted annual DPS history and available grade axes

Annual dividend per share chart2024: 50원20242025: 50원50원2025
Annual dividend (per share · split-adjusted) · as of 2025
Consistency
D
Yield
B-
Safety
F
Reference indicatorView observed cut rates

Paid 2 consecutive years · Raised 0 consecutive years · Yield 2.28% (based on 2025 payment of 50원)

Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 12.21
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
12.21
Beneish M-Score
-2.53

No statistical flag

Sloan accrual
-0.87%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Why has this company moved this way?

Auditable observations with the original numeric evidence.

매출 하락 → 마진 압박 → 현금 악화

Critical

매출이 -3.6% 감소하며 영업이익률이 3.3%에서 2.2%로 하락했다. 영업현금흐름도 동반 감소하여 수익-현금 순환이 약화되고 있다.

Evidence

매출 YoY -3.6% (2023→2024)영업이익률 3.3%→2.2%영업CF 5,194→1,286

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROAPass
  • Positive OCFPass
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesPass

Efficiency

  • Higher gross marginPass
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityWarning

매출채권 증가율이 매출 증가율의 1.5배 초과 (3기 연속) — 매출 인식 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

화장품,의류,완구

This stock is in 화장품,의류,완구: revenue rank 109 of 148, share 0.1%.

109 / 1480.1%revenue share

Who dominates this industry?

  1. 1효성티앤씨8.3%
  2. 2LG생활건강7.3%
  3. 3코웨이4.6%
  4. 4영원무역홀딩스4.6%
  5. 5미스토홀딩스4.6%
  6. 6제로투세븐0.1%

Concentration

DistributedCR3 20.3%
HHI 317148 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedDivergent lenses

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
1.85
Direction
확대
Level
좁음
Years
8

Value lens

P90/P10
8.3
Median P/B
0.82
Level
넓음
n
135

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
2.2%
Interest coverage
59.1x
Return on equity (ROE)
0.6%

Operating margin −5pp

Operating loss
Interest coverageBase 59.1x adverse case -72.9x
Return on equity (ROE)Base 0.6% adverse case -2.3%

Revenue −15%

Tolerable
Interest coverageBase 59.1x adverse case 50.2x
Return on equity (ROE)Base 0.6% adverse case 1.5%

Interest rate +2pp

Tolerable
Interest coverageBase 59.1x adverse case 7.1x
Return on equity (ROE)Base 0.6% adverse case 1.6%

Interest coverage limit

Current margin 2.2pp

Interest coverage limit at an operating margin of 0%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-19

Suppliers disclosed by the company in its 2026-03-19 annual report.

Suppliers without disclosed amount

복원AmcorFlexiblesSingenGmbH

Connections

AI-extracted related companies · for reference

Same theme
제이앤제이글로벌삼성출판사Price comovement r=0.36 (1 year)핑크퐁컴퍼니
🔗 See in the full market map →

Recent filings

Zero to Seven's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About Zero to Seven
What technical signals does Zero to Seven (159580) have?
Zero to Seven current technical signals: death cross (5_20, 0d ago).
Is Zero to Seven a cup-and-handle pattern?
No. Zero to Seven has no valid cup-and-handle signal right now.
What are Zero to Seven's financials and valuation?
Zero to Seven's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy